Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 3
1980 7
1981 9
1982 7
1983 13
1984 10
1985 6
1986 13
1987 28
1988 11
1989 16
1990 13
1991 21
1992 15
1993 13
1994 9
1995 15
1996 15
1997 8
1998 16
1999 8
2000 17
2001 15
2002 17
2003 20
2004 25
2005 32
2006 26
2007 28
2008 21
2009 30
2010 27
2011 23
2012 28
2013 21
2014 29
2015 41
2016 26
2017 33
2018 38
2019 38
2020 42
2021 42
2022 26
2023 23
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

848 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Kawasaki Disease.
Newburger JW, Takahashi M, Burns JC. Newburger JW, et al. J Am Coll Cardiol. 2016 Apr 12;67(14):1738-49. doi: 10.1016/j.jacc.2015.12.073. J Am Coll Cardiol. 2016. PMID: 27056781 Free article. Review.
Indeed, Kawasaki disease is no longer a rare cause of acute coronary syndrome presenting in young adults. Both coronary artery bypass surgery and percutaneous intervention have been used to treat Kawasaki disease patients who develop myocardial ischemia as a consequence of …
Indeed, Kawasaki disease is no longer a rare cause of acute coronary syndrome presenting in young adults. Both coronary artery bypass …
Kawasaki disease: etiopathogenesis and novel treatment strategies.
Agarwal S, Agrawal DK. Agarwal S, et al. Expert Rev Clin Immunol. 2017 Mar;13(3):247-258. doi: 10.1080/1744666X.2017.1232165. Epub 2016 Sep 13. Expert Rev Clin Immunol. 2017. PMID: 27590181 Free PMC article. Review.
Though self-limiting in many cases, it can lead to severe complications like coronary artery aneurysms and thrombo-embolic occlusions, and hence requires early diagnosis and urgent attention to avoid them. Intravenous immunoglobulin (IVIG) with or without aspirin has remai …
Though self-limiting in many cases, it can lead to severe complications like coronary artery aneurysms and thrombo-embolic occlusions, and h …
Diagnosis and management of kawasaki disease.
Saguil A, Fargo M, Grogan S. Saguil A, et al. Am Fam Physician. 2015 Mar 15;91(6):365-71. Am Fam Physician. 2015. PMID: 25822554 Free article. Review.
Treatment for acute disease is intravenous immunoglobulin and aspirin. If there is no response to treatment, patients are given a second dose of intravenous immunoglobulin with or without corticosteroids or other adjunctive treatments. ...
Treatment for acute disease is intravenous immunoglobulin and aspirin. If there is no response to treatment, patients are given a sec …
Kawasaki syndrome (the mucocutaneous lymph node syndrome).
Melish ME. Melish ME. Annu Rev Med. 1982;33:569-85. doi: 10.1146/annurev.me.33.020182.003033. Annu Rev Med. 1982. PMID: 7044280 Review.
Kawasaki Syndrome is a newly recognized clinical entity characterized by multisystem involvement. ...
Kawasaki Syndrome is a newly recognized clinical entity characterized by multisystem involvement. ...
Kawasaki Disease.
Son MBF, Newburger JW. Son MBF, et al. Pediatr Rev. 2018 Feb;39(2):78-90. doi: 10.1542/pir.2016-0182. Pediatr Rev. 2018. PMID: 29437127 Review. No abstract available.
Immunoglobulin-resistant Kawasaki disease.
Marriaga-Núñez B, Arellano-Valdez A, Paz JPA, Bonal-Pérez MA, Montaño-Durón JG, Solórzano-Santos F. Marriaga-Núñez B, et al. Bol Med Hosp Infant Mex. 2023;80(4):260-264. doi: 10.24875/BMHIM.23000078. Bol Med Hosp Infant Mex. 2023. PMID: 37703575 Free article. English.
Kawasaki disease.
Harnden A, Takahashi M, Burgner D. Harnden A, et al. BMJ. 2009 May 5;338:b1514. doi: 10.1136/bmj.b1514. BMJ. 2009. PMID: 19416993 Review. No abstract available.
Kawasaki syndrome.
Rowley AH, Shulman ST. Rowley AH, et al. Clin Microbiol Rev. 1998 Jul;11(3):405-14. doi: 10.1128/CMR.11.3.405. Clin Microbiol Rev. 1998. PMID: 9665974 Free PMC article. Review.
Kawasaki syndrome (KS) is an acute, sometimes fatal vasculitis of young children. ...Common cardiovascular manifestations of the illness include myocarditis, pericardial effusion, and coronary artery aneurysm formation. Treatment with intravenous gamma globulin (IVGG) and …
Kawasaki syndrome (KS) is an acute, sometimes fatal vasculitis of young children. ...Common cardiovascular manifestations of the illn …
Kawasaki disease.
Harnden A, Tulloh R, Burgner D. Harnden A, et al. BMJ. 2014 Sep 17;349:g5336. doi: 10.1136/bmj.g5336. BMJ. 2014. PMID: 25230954 Review. No abstract available.
Kawasaki disease.
Burns JC. Burns JC. Adv Pediatr. 2001;48:157-77. Adv Pediatr. 2001. PMID: 11480756 Review.
If untreated, 1 in 4 children will develop permanent damage to the coronary arteries. Intravenous gamma globulin in conjunction with aspirin is effective in reducing the inflammation and preventing coronary artery abnormalities if administered within the first 10 days of i …
If untreated, 1 in 4 children will develop permanent damage to the coronary arteries. Intravenous gamma globulin in conjunction with aspi
848 results